Interpretation of the post-surgical Somatostatin Receptor Scintigram of a primary neuroendocrine tumor of the thymus: A case report and literature review

International Seminars in Surgical Oncology

Volumn 2, Issue , 2005, Pages

  Leondi, Anastasia ^a   Koutsikos, John ^a   Zerva, Cherry ^a  

^a ALEXANDRA HOSPITAL   (Greece)

Author keywords

Mediastinum; Neuroendocrine carcinoma; Somatostatin receptor scintigraphy; Thymic carcinoid tumor

Indexed keywords

ANTINEOPLASTIC AGENT; PENTETREOTIDE IN 111; SOMATOSTATIN RECEPTOR;

ADULT; CANCER GRADING; CANCER RECURRENCE; CANCER SCINTISCANNING; CASE REPORT; DRUG DISTRIBUTION; DRUG UPTAKE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMAGE ANALYSIS; MALE; MEDIASTINUM; MINIMAL RESIDUAL DISEASE; NEUROENDOCRINE TUMOR; POSTOPERATIVE CARE; REVIEW; SUPERIOR CAVA VEIN OBSTRUCTION; THYMUS CANCER;

EID: 18144372734     PISSN: 14777800     EISSN: None     Source Type: Journal    
DOI: 10.1186/1477-7800-2-7     Document Type: Review

References (20)

1. Wick MR, Scott RE, Li CY, et al.: Carcinoid tumor of the thymus. Mayo Clin Proc 1980, 55:246-54.
2. Chaer R, Massad MG, Evans A, Snow NJ, Geha AS: Primary neuroendocrine tumors of the thymus. Ann Thorac Surg 2002, 74(5):1733-40.
3. Wick MR, Rosai J: Neuroendocrine neoplasms of the thymus. Path Res Pract 1988, 183:188-189.
4. Wick MR, Bernatz PE, Carney JA, et al.: Primary mediastinal carcinoid tumors. Am J Surg Pathol 1982, 6: 95-205.
5. Gibril F, Chen YJ, Schrump DS, Vortmeyer A, Zhuang Z, Lubensky IA, Reynolds JC, Louie A, Entsuah LK, Huang K, Asgharian B, Jensen RT: Prospective study of thymic carcinoids in patients with multiple endocrine neoplasia type 1. J Clin Endocrinol Metab 2003, 88(3):1066-81.
6. Wagner HN, Zsolt, Szabo: Buchanan: Neural Crest structures. In Principles of Nuclear Medicine 2nd edition. Edited by: Shapito B, Gross, Sisson JC. New York: Saunders; 1995:665.
7. Cadigan DG, Hollett PD, Collingwood PW, Ur E: Imaging of a mediastinal thymic carcinoid tumor with radiolabeled somatostatin analogue. Clin Nucl Med 1996, 21(6):487-8.
8. Lastoria S, Vergara E, Palmieri G, Acampa W, Varrella P, Caraco C, Bianco RA, Muto P, Salvatore M: In vivo detection of malignant thymic masses by indium-111-DTPA-D-Phe1-octreotide scintigraphy. J Nucl Med 1998, 39(4):634-9.
9. Satta J, Ahonen A, Parkkila S, Leinonen L, Apaja-Sarkkinen M, Lepojarvi M, Juvonen T: Multiple endocrine neoplastic-associated thymic carcinoid tumour in close relatives: octreotide scan as a new diagnostic and follow-up modality. Two case reports. Scand Cardiovasc J 1999, 33(1):49-53.
10. Loehrer PJ Sr, Wang W, Johnson DH, Ettinger DS: Octreotide Alone or With Prednisone in Patients with Advanced Thymoma and Thymic Carcinoma: An Eastern Cooperative Oncology Group Phase II Trial. J Clin Oncol 22(2):293-9. 2004 Jan 15
11. Slooter GD, Breeman WA, Marquet RL, Krenning EP, van Eijck CH: Anti-proliferative effect of radiolabelled octreotide in a metastases model in rat liver. Int J Cancer 81(5):767-71. 1999 May 31
12. Howell RW: Radiation spectra for Auger-electron emitting radionuclides: report No. 2 of AAPM Nuclear Medicine Task Group No. 6. Med Phys 1992, 19(6):1371-83.
13. Forster GJ, Engelbach MJ, Brockmann JJ, Reber HJ, Buchholz HG, Macke HR, Rosch FR, Herzog HR, Bartenstein PR: Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of (86)Y-DOTATOC and (111)In-DTPA-octreotide. Eur J Nucl Med 2001, 28(12): 743-50. Epub 2001 Oct 20
14. Zuetenhorst JM, Hoefnageli CA, Boot H, Valdes Olmos RA, Taal BG: Evaluation of (111)In-pentetreotide, (131)I-MIBG and bone scintigraphy in the detection and clinical management of bone metastases in carcinoid disease. Nucl Med Commun 2002, 23(8):735-41.
15. Zahner J, Borchard F, Schmitz U, Schneider W: Thymus carcinoid in multiple endocrine neoplasms type I. Dtsch Med Wochenschr 119(5):135-40. 1994 Feb 4
16. Teh BT, Zedenius J, Kytola S, Skogseid B, Trotter J, Choplin H, Twigg S, Farnebo F, Giraud S, Cameron D, Robinson B, Calender A, Larsson C, Salmela P: Thymic carcinoids in multiple endocrine neoplasia type 1. Ann Surg 1998, 228(1):99-105.
17. Grimfjard P, Speel EJM, Stalberg P, Skogseid B: Clinics and genetics in Men 1 related advanced thymic carcinoids: a triple case report including genome wide screening for genetic alterations. Eighth International Workshop on Multiple Endocrine Neoplasia, Grand Rapids, MI 2002. Abstract 15
18. mTc-EDDA/HYNIC-TOC Scintigraphy in Oncological Diagnostics: A Pilot Study. Cancer Biotherapy and Radiopharmaceuticals 19(2):261-270(10). 1 April 2004
19. Tiffet O, Nicholson AG, Ladas G, Sheppard MN, Goldstraw P: A clinicopathologic study of 12 neuroendocrine tumors arising in the thymus. Chest 2003, 124(1):141-6.
20. Boix E, Pico A, Pinedo R, Aranda I, Kovacs K: Ectopic growth hormone-releasing hormone secretion by thymic carcinoid tumour. Clin Endocrinol (Oxf) 2002, 57(1):131-4.